Report Categories
View AllRecent Articles
View All
Is Actelis Asns Stock Showing Strength Asns Q4 Earnings Misses Estimates By 0.37 20260413 1
Is Home Bancshares Homb Stock Consolidating Price At 28.15 Up 2.59 20260408
Is Photronics Plab Stock Breaking Support Price At 40.49 Down 0.88 20260406
Cancer Treatment Costs Soar ACA Could Have Eased Burden Survivor Suggests
Kingfisher Shares Rise as BQ Owner Weathers Easter Sales Dip Eyes Heatwave Boost
Federal Reserve Rate Cut Outlook Dims After Strong Jobs Report
Louisiana Senators Land Sale Near Meta Datacenter Raises Ethics Questions
American Graphics Signs Expands Fleet Graphics Installation Network Nationwide to All 50 States
KHC Q1 2026 Earnings EPS Beats Estimates by 1417 Shares Rise
TCBK Q1 2026 Earnings EPS Surpasses Estimates by 527 Shares Edge Lower
RideNow Group Inc Q1 2026 Earnings Narrower Loss Beats Expectations as Stock Slips
OFG Bancorp OFG Q1 2026 Earnings Strong EPS Beat Offsets Revenue Uncertainty
FCEL Q1 2026 Earnings EPS Surprises to the Upside Shares Dip Despite Narrowing Losses
Oxford Square Capital Notes OXSQG Edge Lower as FixedIncome Pressures Persist
Venture Global VG Finds Footing Near Support Tests Key Resistance Levels
Hims Hers Health HIMS Edges Higher Amid Steady Trading Key Levels in Focus
Chunghwa Telecom CHT Holds Steady Near Support as Telecom Sector Faces Headwinds
Lawmakers Vote to Restrict Wall Street Landlords Symbolic About Whos In Charge
AI Data Centers Strain Power Grid Potentially Raising Consumer Utility Bills
Silver Futures Surge into Overbought Territory as VC PMI Points to 82 Resistance
Cambodian Opposition Leaders Partial Pardon May Signal Shifting Political Landscape
DTSS Datasea plunges 585 after Q2 loss widens missing estimates by 716
CCLD CareCloud stock gains 244 even as its Q4 2025 EPS falls short of analyst consensus estimates
AIM ImmunoTech Q4 loss widens as earnings miss targets by 48 percent shares fall 39 percent
Cheesecake CAKE Stock Price Movement 034 20260420
Brazil GRO Stock Growth Potential Slips 20260420
LUCD Lucid Diagnostics shares rise 44 percent on Q4 2025 EPS beat and 83 percent year over year revenue growth